| The
Science Behind Microcyn Technology
Microcyn Technology is a unique shelf-stable pH-neutral oxychlorine
compound.
Microcyn has been studied
for its clinical benefits and safety, a number
of these findings peer-reviewed and published. These studies demonstrate
that the Microcyn Technology delivers wound healing
benefits, reduction of inflammation, cure or
improvement of infection and antimicrobial activity;
all while remaining safe and biocompatible as
evidenced in a 2007 study published in the International
Wound Journal. The reason for
this safety is that mammalian cells have evolved
with special pumps to regulate the active ingredients
in Microcyn Technology while viruses, spores
and bacteria, including drug-resistant bacteria,
lack this ability.
One
of Microcyn Technology’s
primary modes of action is its ability to treat
a wide range of pathogens, including antibiotic-resistant
strains of bacteria (including MRSA and VRE),
viruses, fungi and spores, as it is described
in a study published in May/June 2006 issue of Diabetic
Microvascular Complications Today. It
has also been demonstrated in research studies
that Microcyn induces vasodialation and inhibits
inflammation.
The Microcyn Technology chemistry
mimics the same oxychlorine composition as
that manufactured by neutrophils in the body’s
immune system.
Neutrophils are the most abundant type of white
blood cells in humans and form an integral part
of the immune system. As demonstrated in the
video below, a human neutrophil senses and moves
toward a yeast cell. Next, it surrounds and digests
the yeast cell. The neutrophil uses an oxidative
or respiratory burst to produce a number of active
ingredients including hypochlorous acid to kill
the yeast.
|
